Purchase Order 75N90018P00748
- Not listed
- This $3,742.63 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract supports the delivery and installation of Miltenyi's proprietary CliniMACS cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated reagents and consumables. This award is a standalone...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company, to provide specialized scientific instruments, reagents, and services to support the NIH's biomedical research and cell therapy development programs. The $5,420 firm fixed-price purchase order has a period of performance through September 2023. Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical...
- This $142,174 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract is for the supply of CliniMACS Prodigy Essential Service Units to support the NIH Clinical Center's cell therapy manufacturing capabilities. This award is part of a larger $2.3 million indefinite delivery contract (IDC) that Miltenyi...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The $7,009 contract supports the delivery and installation of Miltenyi Biotec's CliniMACS Prodigy cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
- This federal contract award from the Department of Health and Human Services National Institutes of Health (NIH) Clinical Center was issued to Miltenyi Biotec, Inc., a global biotechnology company that provides products and services to support biomedical research and cell and gene therapy. The $1,090,887.29 Firm Fixed Price Delivery Order contract is for the provision of proprietary CliniMACS cell isolation reagents and consumables compatible with government-owned Miltenyi cell separation...
- This contract is for the purchase of CliniMACS PLUS reagents and consumables from Miltenyi Biotec, Inc. by the National Institutes of Health (NIH) Clinical Center. The $248,000 firm fixed-price purchase order will provide proprietary cell isolation reagents and supplies compatible with the government-owned CliniMACS instruments used by the Clinical Center Cell Processing Section to manufacture purified cell products in support of FDA-approved clinical trials and protocols. This is a sole...
- This is a $4,250 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of biotechnology products. The contract is not set aside and runs through May 2011. Miltenyi Biotec provides specialized scientific instruments, reagents, and services to support biomedical research, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables under this award...
This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good Manufacturing Practice-compliant production of investigational cell therapy products used in NIH clinical trials. This order is part of a larger $2.3 million single-award indefinite delivery contract (IDC) between Miltenyi Biotec and the NIH Clinical Center, which ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation through September 2024, with options to extend to 2027. Miltenyi Biotec has extensive experience as a prime contractor for numerous federal agencies, frequently providing specialized laboratory equipment, reagents, and technical support services to support biomedical research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($116) | 9/12/24 | |
| Not listed | Not listed | $5.0k | 8/24/18 |